Ergoteles’s Accendra Health ACH Stock Holding History

Ergoteles’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,267	Closed	-$603K	–	1493
2021 Q3	$603K	Buy	+19,267	New	+$758K	0.02%	513

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles's ACH Position: Q4 2021 in Review

Ergoteles sold out of Accendra Health (ACH) in Q4 2021, closing a stake of 19,267 shares — an estimated $603K sold.

Ergoteles first reported a position in ACH in Q3 2021 and held it in 1 quarter. The position peaked at $603K in Q3 2021. 272 funds tracked by Wall St. Rank hold ACH as of Q4 2021.

Ergoteles reported no remaining Accendra Health position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 19,267 Accendra Health shares in Q4 2021, an estimated $603K.
Ergoteles first reported a position in Accendra Health in Q3 2021 and held it in 1 quarter.
Ergoteles's Accendra Health position peaked at $603K in Q3 2021.
272 funds tracked by Wall St. Rank held Accendra Health as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.